Private Valuation & Funding Round Tracker · Abridge

Abridge funding rounds & valuation history

Name: Abridge Funding Rounds & Valuation History
Creator: growthnavigatefunding.net

Abridge, the Pittsburgh company whose ambient AI listens to doctor–patient conversations and drafts clinical notes inside health-system records. Funding from the Series C (Feb 2024) to the Series E (Jun 2025), sourced to Abridge, TechCrunch and Fortune.

Last updated: 14 Nov 2026 (IST). Every figure re-checked against the linked sources that day. Rows: 3 Currency: US$, nominal

⬇ Download CSV Cite this dataset Methodology & status definitions

Last closed round Closed

$5.3B

$300M Series E, Jun 2025

Raised in rounds listed

$700M

Sum of 3 closed rounds with a disclosed amount (GNF calc.)

Largest round

$300M

Series E, Jun 2025

Closed rounds listed

Feb 2024 to Jun 2025

Round history

Newest first. Dashed badges and striped rows are not closed transactions. “—” means the source does not disclose the figure or it cannot be computed on the same basis; see the note in each row.

Abridge funding rounds, Feb 2024 to Jun 2025
Date	Status	Round	Amount	Lead / buyer	Valuation	Val. ÷ run-rate	Source
23 Jun 2025	Closed round	Series EKhosla Ventures joined (Abridge).	$300M	Andreessen Horowitz	$5.3BReported (WSJ via TechCrunch; Fortune)1.93× vs prior closed	—Not disclosedNo run-rate stated in the announcement	Abridge, 23 Jun 2025Also: TechCrunch, 24 Jun 2025, Fortune, 11 Jun 2026
17 Feb 2025	Closed round	Series DWith Bessemer Venture Partners and others (Abridge).	$250M	Elad GilWith: IVP	$2.75BPost-money, reported (Fortune)	—Not disclosedNo run-rate stated in the announcement	Abridge, 17 Feb 2025Also: Fortune, 17 Feb 2025
23 Feb 2024	Closed round	Series C	$150M	Lightspeed Venture Partners	Not disclosedNo company valuation stated by the source	—Not disclosedNo run-rate stated in the announcement	Abridge, 23 Feb 2024

Step-up = valuation ÷ the prior closed valuation (GNF calc.), shown only where both figures were stated or reported and neither is a lower bound.

Valuation at each closed round

Valuations as stated or reported at each closed round with a disclosed figure; talks, tenders and filings are not plotted.

Series DFeb 2025$2.75B
Series EJun 2025$5.3B

Sources: Abridge, TechCrunch, Fortune. US$ billions, linear scale.

Timeline

Each round and share sale, oldest first.

23 Feb 2024 · Closed
Series C: $150M led by Lightspeed Venture Partners.
17 Feb 2025 · Closed
Series D: $250M at $2.75B led by Elad Gil.
23 Jun 2025 · Closed
Series E: $300M at $5.3B led by Andreessen Horowitz.

Still private: Abridge has not filed for an IPO and has not been acquired.

Cite this dataset

Free to quote with a link back. Copy this citation:

Abridge Funding Rounds & Valuation History. Private Valuation & Funding Round Tracker, GrowthNavigateFunding.net, updated 14 Nov 2026. https://growthnavigatefunding.net/funding/abridge/

Download the data

The same 3 rows as the table: numeric US$ columns, empty cells where a figure is not disclosed, and a source URL for every row.

File: abridge-rounds.csv (UTF-8, comma-separated)
Stable URL: https://growthnavigatefunding.net/wp-content/uploads/2026/11/abridge-rounds.csv
Columns: id, date, date_precision, status, transaction_type, round, amount_usd_low, amount_usd_high, lead_or_buyer, co_leads, valuation_usd_low, valuation_usd_high, valuation_basis, valuation_to_run_rate_multiple, multiple_bound, multiple_basis, step_up_vs_prior_closed, price_per_share_usd_low, price_per_share_usd_high, shares, source, source_url, other_source_urls, notes, last_updated
Updated: 14 Nov 2026 (IST)

⬇ Download CSV

Methodology & status definitions

How each row is labelled and calculated.

Closed round

A primary round announced by the company or confirmed in the press, bringing new money to the company.

Valuation ÷ run-rate

Post-money valuation ÷ the run-rate the company stated in that announcement (GNF calc.). Where the run-rate is “crossed” or “over” a figure, the multiple is shown as “under X×”. No row qualifies here unless shown, so no multiple is invented.

What is not a separate row

A reported 2026 Series E extension (amount not confirmed in a captured authority source), Eli Lilly’s 2026 strategic investment (amount undisclosed; Fortune), and the Series A and B rounds.

Updates & corrections

This page stays at one address and is updated in place; the “Last updated” date above drives the citation and the dataset metadata. Corrections: hello@growthnavigatefunding.net. Informational only; not investment advice.

Changelog

14 Nov 2026: Dataset first compiled (AI-50 batch, not yet published).

Abridge Funding Rounds & Valuation History (2024–2025)